Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014999 |
| CAS No | NA |
| Mol.F. | C15H17N5O4 |
| Mol.Wt. | 331.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141000 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O6S |
| Mol.Wt. | 567.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141001 |
| CAS No | NA |
| Mol.F. | C26H31F2N7O5S |
| Mol.Wt. | 591.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141002 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141003 |
| CAS No | NA |
| Mol.F. | C23H28FN7O5S |
| Mol.Wt. | 533.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141004 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141005 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141006 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141007 |
| CAS No | NA |
| Mol.F. | C25H29F2N7O6S |
| Mol.Wt. | 593.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141008 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O5S |
| Mol.Wt. | 407.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141009 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141010 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O6S |
| Mol.Wt. | 423.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141011 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141012 |
| CAS No | NA |
| Mol.F. | C15H22ClN5O6S |
| Mol.Wt. | 435.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141013 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141014 |
| CAS No | NA |
| Mol.F. | C21H33N7O9S |
| Mol.Wt. | 559.6 |
| INV STATUS | CUSTOM SYNTHESIS |